YSPH alumna Margaret Mayer embraces challenge of grant management at the National Cancer Institute
This Alumni Spotlight focuses on Margaret Mayer, PhD ’19 (Chronic Disease Epidemiology), MPH ’16 (Chronic Disease Epidemiology), the program director in the Tobacco Cancer Research Branch at the National Cancer Institute.
Transitioning Cancer Survivors Away From Oncologic Care
October was Breast Cancer Awareness month and the sudden influx of pink in our homes, on our televisions, in our workplaces, and in local businesses reminded us that we still lose far too many of our loved ones to cancer, not only in this form but in so many others. While the race to discover new diagnostics and treatments remains imperative, there is another pressing issue emerging for patients with cancer. With advances in early detection, treatment, and oncologic outcomes, many individuals diagnosed with cancer are now living longer and are thus more likely to die from or develop conditions other than cancer. Two thirds of all individuals diagnosed with cancer now live 5 years or more past diagnosis, and the number of such "long-term" survivors in the U.S. will rise from 15.5 million to 20 million by 2026. As such, there is a pressing need to encourage the shift in survivorship care away from oncologists back to primary care physicians and other non-oncologists.Source: MedPage Today
Witches and Mombies! Happy Halloween from Where We Live
The “Mombies” is a group of Moms of all ages that have been coordinating to “dance to donate” since 2016. They have raised over $170,000 for breast cancer research to date - and their dance videos have been seen by millions.Source: CT Public
3 Questions on… The Value of Diet & Exercise During Chemotherapy
Do exercise and a healthy diet improve outcomes for cancer patients? A new study investigated whether such an intervention helps patients with Stages I-III breast cancer undergoing initial chemotherapy. The data showed that women who underwent the intervention saw improvements in diet quality, physical activity levels, and pathological complete response. That outcome was a surprise for the study authors and others.Source: Oncology Times
Yale Cancer Center Researchers Awarded 2023-2024 Grants from the Breast Cancer Research Foundation
The Breast Cancer Research Foundation (BCRF) Scientific Advisory Board and its Board of Directors recently announced its $60.2 million commitment to fund breast cancer research in 2023-2024, supporting more than 250 scientists at leading academic and medical institutions, including eight grants at Yale Cancer Center and Smilow Cancer Hospital.
PFAS and Phenols Linked to Different Cancers in Women of Different Races
A new federally-funded study in the Journal of Exposure Science & Environmental Epidemiology has found that compounds called phenols, and the synthetic chemicals PFAS, were linked to different kinds of cancer in white women and women of color. PFAS were linked to ovarian and uterine cancers mainly in white women, and phenols were linked more to breast cancer in non-white women. Phenols and PFAS are found in hundreds of daily consumer products. The researchers stated that the racial differences are particularly impactful because of racial disparities in exposure to these chemicals. Nicole Deziel, member of the Yale Cancer Center and associate professor of epidemiology (environmental sciences) at Yale School of Public Health, who is not associated with the study, said the findings “provided a lot of new information suggesting that exposure to PFAS could be associated with a variety of hormonally related cancers, particularly in women.”Source: CT Public Radio
Engaging People with Low-Grade Glioma in Cancer Research
Some people with low-grade glioma, a type of brain tumor, can live for years, even decades, without the disease worsening. But eventually these cancers start to grow, and little is known about why—or how—this happens. An NCI-supported study called OPTIMUMExit Disclaimer (Optimizing Engagement in Discovery of Molecular Evolution of Low-Grade Glioma) could provide some answers.Source: National Cancer Institute
Research reveals boosting strategies that mitigate risks of COVID-19 in cancer patients
New research led by scientists at Yale University and the University of North Carolina at Charlotte finds that the rate at which additional COVID-19 boosters are needed for cancer patients depends on the treatment they are receiving.
Study: Low-Risk Long-Term Cancer Survivors Much More Likely to Die of Noncancer Causes
A new study led by Yale University researchers examined the cancer- and noncancer-related mortality rates of long-term adult cancer survivors to better understand and quantify their associated health risks. The findings could help reduce large-scale care inefficiencies and improve the quality of care for long-term cancer survivors, who have unique cancer and noncancer health needs.
Screening Mammograms Carry Risks for Older Women, Study Finds
Although some guidelines recommend continuing screening for older women, this new study emphasizes the importance of assessing potential harms associated with testing, such as overdiagnosis, which, researchers say, can negatively affect quality of life.
Aerobic exercise may reduce chemotherapy-induced peripheral neuropathy in ovarian cancer
A 6-month aerobic exercise intervention significantly improved self-reported chemotherapy-induced peripheral neuropathy among women who underwent chemotherapy for ovarian cancer, according to study results published in JAMA Network Open.Source: Healio
How Incarceration Raises Risk of Cancer Diagnosis and Death—Even After Release
The United States has one of the highest incarceration rates in the world, with nearly 2 million people in the criminal justice system facing potential barriers to accessing timely, quality care. Now, Yale researchers are finding that individuals with a history of incarceration are more likely to be diagnosed with cancer and are less likely to survive the disease.